We can’t show the full text here under this license. Use the link below to read it at the source.
The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action
Possible ways 5-methoxy-N,N-dimethyltryptamine may help treat alcohol use disorder
AI simplified
Abstract
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) shows potential therapeutic mechanisms that could alleviate symptoms of (AUD).
- 5-MeO-DMT is associated with inducing mystical experiences and , which may enhance psychological flexibility and mindfulness.
- These effects could potentially decrease AUD symptoms by addressing psychiatric mood-related comorbidities linked to negative reinforcement and self-medication.
- Preliminary evidence suggests 5-MeO-DMT modulates neural oscillations, including increases in gamma and theta waves, which may support ego-dissolution and improved emotion regulation.
- Animal studies indicate that 5-MeO-DMT promotes neuroplasticity, exhibits anti-inflammatory properties, and affects serotonin receptors, offering clinical implications for AUD and related mood disorders.
- The findings highlight the need for further research to clarify the therapeutic mechanisms of 5-MeO-DMT in treating AUD.
AI simplified
Key numbers
66%
Reduction in Alcohol Consumption
Percentage of respondents experiencing reduced symptoms linked to mystical experiences.
515
Survey Participants
Total number of survey participants reporting on mystical experiences.
1
Case Study Participants
Number of participants in a case study demonstrating benefits.